IL55274A
(en)
*
|
1978-08-02 |
1982-08-31 |
Yissum Res Dev Co |
4-(2,6-dihydroxy-4-(dimethylheptyl)phenyl)substituted 2-pinen-10-ol and pinane derivatives,their preparation and pharmaceutical compositions comprising them
|
US4442089A
(en)
*
|
1982-07-06 |
1984-04-10 |
E. R. Squibb & Sons, Inc. |
Method for treating glaucoma with topical or systemic ACE inhibitor compositions
|
US4826812A
(en)
*
|
1982-12-27 |
1989-05-02 |
Schering Corporation |
Antiglaucoma agent
|
IL80411A
(en)
*
|
1986-10-24 |
1991-08-16 |
Raphael Mechoulam |
Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them
|
IL92238A
(en)
*
|
1989-11-07 |
1995-07-31 |
Yissum Res Dev Co |
ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation
|
US5284867A
(en)
*
|
1989-11-07 |
1994-02-08 |
Yissum Research Development Company Of The Hebrew University In Jerusalem |
NMDA-blocking pharmaceutical compositions
|
US5521215A
(en)
*
|
1989-11-07 |
1996-05-28 |
Ramot University Authority For Applied Research And Industrial Development Ltd. |
NMDA-blocking pharmaceuticals
|
US6096740A
(en)
*
|
1990-11-06 |
2000-08-01 |
Ramot University Authority For Applied Research And Industrial Development Ltd. |
Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions
|
US5635530A
(en)
*
|
1991-09-12 |
1997-06-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
(3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them
|
US5538993A
(en)
*
|
1991-09-12 |
1996-07-23 |
Yissum Research Development Company |
Certain tetrahydrocannabinol-7-oic acid derivatives
|
GB9807639D0
(en)
*
|
1998-04-14 |
1998-06-10 |
Kennedy Rheumatology Inst |
Anti-inflammatory agents
|
ATE247097T1
(de)
*
|
1998-05-04 |
2003-08-15 |
Univ Connecticut |
Analgetische und immunomodulierende cannabinoiden
|
US5847128A
(en)
*
|
1998-05-29 |
1998-12-08 |
Virginia Commonwealth University |
Water soluble derivatives of cannabinoids
|
US7589220B2
(en)
*
|
1998-06-09 |
2009-09-15 |
University Of Connecticut |
Inhibitors of the anandamide transporter
|
US7897598B2
(en)
*
|
1998-06-09 |
2011-03-01 |
Alexandros Makriyannis |
Inhibitors of the anandamide transporter
|
US7161016B1
(en)
|
1998-11-24 |
2007-01-09 |
University Of Connecticut |
Cannabimimetic lipid amides as useful medications
|
US7276613B1
(en)
|
1998-11-24 |
2007-10-02 |
University Of Connecticut |
Retro-anandamides, high affinity and stability cannabinoid receptor ligands
|
US7393842B2
(en)
*
|
2001-08-31 |
2008-07-01 |
University Of Connecticut |
Pyrazole analogs acting on cannabinoid receptors
|
US8084467B2
(en)
*
|
1999-10-18 |
2011-12-27 |
University Of Connecticut |
Pyrazole derivatives as cannabinoid receptor antagonists
|
US7741365B2
(en)
*
|
1999-10-18 |
2010-06-22 |
University Of Connecticut |
Peripheral cannabinoid receptor (CB2) selective ligands
|
US6943266B1
(en)
*
|
1999-10-18 |
2005-09-13 |
University Of Connecticut |
Bicyclic cannabinoid agonists for the cannabinoid receptor
|
US6900236B1
(en)
|
1999-10-18 |
2005-05-31 |
University Of Connecticut |
Cannabimimetic indole derivatives
|
US7119108B1
(en)
*
|
1999-10-18 |
2006-10-10 |
University Of Connecticut |
Pyrazole derivatives as cannabinoid receptor antagonists
|
US6995187B1
(en)
|
1999-10-18 |
2006-02-07 |
University Of Connecticut |
Peripheral cannabinoid receptor (CB2) selective ligands
|
EP1361876A4
(fr)
*
|
2001-01-26 |
2004-03-31 |
Univ Connecticut |
Nouveaux ligands cannabimimetiques
|
CA2436133A1
(fr)
|
2001-01-29 |
2002-08-08 |
University Of Connecticut |
Aminoalkylindoles cannabimimetiques selectifs d'un recepteur
|
WO2002076480A1
(fr)
*
|
2001-03-28 |
2002-10-03 |
Floripes Medina Gallo |
Extrait de cannabis sativa destine au traitement de la migraine
|
EP1414775B1
(fr)
*
|
2001-07-13 |
2012-12-19 |
The University of Connecticut |
Cannabinoide bicyclique
|
JP2005510492A
(ja)
*
|
2001-10-26 |
2005-04-21 |
ユニバーシティ オブ コネチカット |
新規な種類の効力のあるカンナビミメティックリガンド
|
US20040171613A1
(en)
*
|
2001-12-27 |
2004-09-02 |
Japan Tobacco Inc. |
Therapeutic agent for non-immediate type allergic diseases
|
WO2003075917A1
(fr)
*
|
2002-03-08 |
2003-09-18 |
Signal Pharmaceuticals, Inc. |
Polytherapie destinee a traiter, prevenir ou gerer des troubles proliferatifs et des cancers
|
US20050137251A1
(en)
*
|
2002-03-18 |
2005-06-23 |
Aaron Garzon |
Dexanabinol and dexanabinol analogs regulate inflammation related genes
|
AU2003265663A1
(en)
|
2002-08-23 |
2004-03-11 |
University Of Connecticut |
Keto cannabinoids with therapeutic indications
|
JP2006524247A
(ja)
*
|
2003-04-24 |
2006-10-26 |
マリンクロッド・インコーポレイテッド |
(+)−p−メンタ−2,8−ジエン−1−オールの製造方法
|
CA2573859A1
(fr)
*
|
2004-07-19 |
2006-01-26 |
Cilag Ltd. |
Procede de fabrication de tetrahydrocannabinol pur
|
EP1928853A4
(fr)
|
2005-09-29 |
2011-02-16 |
Amr Technology Inc |
Procédé pour la production de delta-9-tétrahydrocannabinol
|
US9585867B2
(en)
|
2015-08-06 |
2017-03-07 |
Charles Everett Ankner |
Cannabinod formulation for the sedation of a human or animal
|